Bronchiolitis Obliterans Syndrome (BOS) Terminated Phase Trials for Azithromycin (DB00207)

Also known as: Bronchiolitis Obliterans (BO) / Bronchiolitis Obliterans / Obliterative Bronchiolitis / Bronchiolitis Obliterans Syndrome / Obliterating fibrous bronchiolitis (disorder) / Bronchiolitis fibrosa obliterans (disorder) / Obliterative bronchiolitis (disorder)

IndicationStatusPhase
DBCOND0071683 (Bronchiolitis Obliterans Syndrome (BOS))TerminatedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01327625Efficacy Study of Azithromycin-based Therapy for Bronchiolitis ObliteransTreatment